Skip to main content
. 2020 Jan 17;141(9):751–767. doi: 10.1161/CIRCULATIONAHA.119.042559

Figure 7.

Figure 7.

Mechanistic overview. Proposed therapeutic mode of action for the antifibrotic compounds bufalin and lycorine in angiotensin II–mediated diastolic dysfunction. Treatment with the lead natural compound results in a decline in microRNA (miR) 671-5p levels in cardiac fibroblasts, which, in turn, leads to derepression of its target selenoprotein P1 (SEPP1). LV indicates left ventricular.